Evolus (EOLS) Total Non-Current Liabilities (2017 - 2021)

Evolus (EOLS) reported Total Non-Current Liabilities of $130.9 million for Q4 2021, down 45.58% on a YoY basis from $240.5 million in Q4 2020, and down 45.58% quarter-over-quarter from $240.5 million in Q4 2020.

Evolus (EOLS) Total Non-Current Liabilities (2017 - 2021) Analysis & Trends

Evolus has reported Total Non-Current Liabilities for 5 years, with the latest figure at $130.9 million in Q4 2021.

  • For the quarter ending Q4 2021, Total Non-Current Liabilities fell 45.58% year-over-year to $130.9 million; the trailing twelve-month figure through Dec 2021 stood at $130.9 million (down 45.58% YoY), and the FY2021 full-year result was $130.9 million, down 45.58% from the prior year.
  • Total Non-Current Liabilities for Q4 2021 stood at $130.9 million, down from $240.5 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $240.5 million in Q4 2020, with the low at $34.8 million in Q1 2018.
  • Historically, Total Non-Current Liabilities has averaged $108.3 million across 5 years, with a median of $114.4 million in 2019.
  • Annual changes were most pronounced in 2018 — Total Non-Current Liabilities slumped 83.64% — and 2019, when it jumped 225.1%.
  • Evolus' Total Non-Current Liabilities stood at $227.8 million in 2017, then tumbled by 83.64% to $37.3 million in 2018, then surged by 212.14% to $116.3 million in 2019, then soared by 106.77% to $240.5 million in 2020, then sank by 45.58% to $130.9 million in 2021.
  • The last three Total Non-Current Liabilities figures came in at $130.9 million (Q4 2021), $240.5 million (Q4 2020), and $117.3 million (Q1 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 18.28 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.44 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.13 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.81 Bn
10 Evolus 435.45 Mn 385.65 Mn 48.90 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 130.87 Mn
Dec 31, 2020 240.48 Mn
Mar 31, 2020 117.33 Mn
Dec 31, 2019 116.30 Mn
Jun 30, 2019 114.43 Mn
Mar 31, 2019 99.67 Mn
Dec 31, 2018 37.26 Mn
Sep 30, 2018 37.31 Mn
Jun 30, 2018 35.20 Mn
Mar 31, 2018 34.81 Mn
Dec 31, 2017 227.78 Mn